Literature DB >> 14770226

Design and synthesis of a template-assembled oligomannose cluster as an epitope mimic for human HIV-neutralizing antibody 2G12.

Hengguang Li1, Lai-Xi Wang.   

Abstract

The synthesis and antibody-binding affinity of a novel template-assembled oligomannose cluster as an epitope mimic for human anti-HIV antibody 2G12 are described. Cholic acid was chosen as the scaffold and three high-mannose type oligosaccharide (Man(9)GlcNAc(2)Asn) moieties were selectively attached at the 3alpha, 7alpha, and 12alpha-positions of the scaffold through a series of regioselective transformations. Binding studies revealed that the synthetic oligosaccharide cluster is 46-fold more effective than the subunit Man(9)GlcNAc(2)Asn in inhibiting 2G12-binding to immobilized gp120. The scaffold approach described in this paper provides an avenue to designing more effective epitope mimics for antibody 2G12 in the hope of developing a carbohydrate-based vaccine against HIV-1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14770226     DOI: 10.1039/b314565d

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  22 in total

Review 1.  Recent strategies targeting HIV glycans in vaccine design.

Authors:  Satoru Horiya; Iain S MacPherson; Isaac J Krauss
Journal:  Nat Chem Biol       Date:  2014-12       Impact factor: 15.040

2.  Anti-Oligomannose Antibodies as Potential Serum Biomarkers of Aggressive Prostate Cancer.

Authors:  Denong Wang; Laila Dafik; Rosalie Nolley; Wei Huang; Russell D Wolfinger; Lai-Xi Wang; Donna M Peehl
Journal:  Drug Dev Res       Date:  2013-03       Impact factor: 4.360

Review 3.  Designing synthetic vaccines for HIV.

Authors:  Alberto Fernández-Tejada; Barton F Haynes; Samuel J Danishefsky
Journal:  Expert Rev Vaccines       Date:  2015-03-31       Impact factor: 5.217

4.  Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12.

Authors:  Daniel A Calarese; Hing-Ken Lee; Cheng-Yuan Huang; Michael D Best; Rena D Astronomo; Robyn L Stanfield; Hermann Katinger; Dennis R Burton; Chi-Huey Wong; Ian A Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-07       Impact factor: 11.205

5.  Crystal structure of the HIV neutralizing antibody 2G12 in complex with a bacterial oligosaccharide analog of mammalian oligomannose.

Authors:  Robyn L Stanfield; Cristina De Castro; Alberto M Marzaioli; Ian A Wilson; Ralph Pantophlet
Journal:  Glycobiology       Date:  2014-11-07       Impact factor: 4.313

Review 6.  Synthetic carbohydrate antigens for HIV vaccine design.

Authors:  Lai-Xi Wang
Journal:  Curr Opin Chem Biol       Date:  2013-12       Impact factor: 8.822

Review 7.  Recent advances in synthetic carbohydrate-based human immunodeficiency virus vaccines.

Authors:  Zhenyuan Wang; Chunjun Qin; Jing Hu; Xiaoqiang Guo; Jian Yin
Journal:  Virol Sin       Date:  2016-03-17       Impact factor: 4.327

8.  A yeast glycoprotein shows high-affinity binding to the broadly neutralizing human immunodeficiency virus antibody 2G12 and inhibits gp120 interactions with 2G12 and DC-SIGN.

Authors:  Robert J Luallen; Hu Fu; Caroline Agrawal-Gamse; Innocent Mboudjeka; Wei Huang; Fang-Hua Lee; Lai-Xi Wang; Robert W Doms; Yu Geng
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

9.  A glycoconjugate antigen based on the recognition motif of a broadly neutralizing human immunodeficiency virus antibody, 2G12, is immunogenic but elicits antibodies unable to bind to the self glycans of gp120.

Authors:  Rena D Astronomo; Hing-Ken Lee; Christopher N Scanlan; Ralph Pantophlet; Cheng-Yuan Huang; Ian A Wilson; Ola Blixt; Raymond A Dwek; Chi-Huey Wong; Dennis R Burton
Journal:  J Virol       Date:  2008-04-23       Impact factor: 5.103

10.  An engineered Saccharomyces cerevisiae strain binds the broadly neutralizing human immunodeficiency virus type 1 antibody 2G12 and elicits mannose-specific gp120-binding antibodies.

Authors:  Robert J Luallen; Jianqiao Lin; Hu Fu; Karen K Cai; Caroline Agrawal; Innocent Mboudjeka; Fang-Hua Lee; David Montefiori; David F Smith; Robert W Doms; Yu Geng
Journal:  J Virol       Date:  2008-04-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.